Mesoblast (MESO) Revenue (2016 - 2023)

Mesoblast (MESO) has 8 years of Revenue data on file, last reported at -$5.4 million in Q2 2023.

• For the quarter ending Q2 2023, Revenue fell 257.89% year-over-year to -$5.4 million; the trailing twelve-month figure through Jun 2023 stood at $776000.0 (down 93.17% YoY), and the FY2025 full-year result was $17.2 million, changed N/A from the prior year.
• Revenue slipped to -$5.4 million in Q2 2023, from $1.9 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $26.2 million in Q2 2020 to a low of -$5.4 million in Q2 2023.
• A 5-year average of $3.0 million and a median of $2.0 million in 2021 frame the typical range for Revenue.
• Across the five-year window, Revenue surged 1233.71% in 2020 and sank 257.89% in 2023, its largest moves.
• Tracing MESO's Revenue over 5 years: stood at $2.0 million in 2019, then rose by 13.81% to $2.2 million in 2020, then surged by 57.79% to $3.5 million in 2021, then plunged by 44.0% to $2.0 million in 2022, then slumped by 370.81% to -$5.4 million in 2023.
• Business Quant data shows MESO's Revenue at -$5.4 million in Q2 2023, $1.9 million in Q1 2023, and $2.0 million in Q4 2022.